These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3756916)

  • 21. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
    Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antileukemic effects of recombinant human tumor necrosis factor alpha (rh-TNF alpha) with cyclophosphamide or methotrexate on leukemia L1210 and leukemia P388 in mice.
    Warzocha K; Robak T
    Acta Haematol Pol; 1992; 23(1):55-62. PubMed ID: 1615753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of tumors to synthesize tumor necrosis factor-alpha in situ using 5,6-dimethylxanthenone-4-acetic acid: a novel approach to cancer therapy.
    Joseph WR; Cao Z; Mountjoy KG; Marshall ES; Baguley BC; Ching LM
    Cancer Res; 1999 Feb; 59(3):633-8. PubMed ID: 9973211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antitumor activity of tumor necrosis factor (TNF) in vitro and in vivo].
    Haranaka K; Satomi N; Sakurai A
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1387-93. PubMed ID: 6742865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor pretargeting with avidin improves the therapeutic index of biotinylated tumor necrosis factor alpha in mouse models.
    Gasparri A; Moro M; Curnis F; Sacchi A; Pagano S; Veglia F; Casorati G; Siccardi AG; Dellabona P; Corti A
    Cancer Res; 1999 Jun; 59(12):2917-23. PubMed ID: 10383155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Damaging action of human recombinant TNF on tumor vessels as an aspect of its anti-neoplastic action against Meth A sarcoma in mice].
    Nakamura H; Motoyoshi S; Seto Y; Kadokawa T; Nakata K; Iida M; Taguchi T
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):91-9. PubMed ID: 3800409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic efficacy of recombinant tumor necrosis factor alpha in an experimental model of human prostatic carcinoma.
    Sherwood ER; Pitt Ford TR; Lee C; Kozlowski JM
    J Biol Response Mod; 1990 Feb; 9(1):44-52. PubMed ID: 2319260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
    Song Y; Shen K; Yu JR
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Schedule-dependent enhanced lethality with combined administration of actinomycin D and tumor necrosis factor in mice.
    Buckley NJ; Walther PJ; Das AK; Poulton SH
    J Biol Response Mod; 1989 Jun; 8(3):287-96. PubMed ID: 2746299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: A possible oxygen effect.
    Silver DF; Piver MS
    Gynecol Oncol; 1999 May; 73(2):280-4. PubMed ID: 10329047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of indomethacin, cytokines, and cyclosporin A on tumor growth and the subsequent development of cancer cachexia.
    Gelin J; Andersson C; Lundholm K
    Cancer Res; 1991 Feb; 51(3):880-5. PubMed ID: 1988128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
    Tomazic VJ; Farha M; Loftus A; Elias EG
    J Immunol; 1988 Jun; 140(11):4056-61. PubMed ID: 3372997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Synergistic effect of bromocriptine combining tumor necrosis factor-alpha on reversing multidrug resistance in a nude mouse model of liver neoplasm].
    Ding L; Chen XP; Zhang ZW; Wang H; Cao B; Wang ZH; Li CL
    Zhonghua Wai Ke Za Zhi; 2005 Oct; 43(19):1248-53. PubMed ID: 16271222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors.
    Li C; Price JE; Milas L; Hunter NR; Ke S; Yu DF; Charnsangavej C; Wallace S
    Clin Cancer Res; 1999 Apr; 5(4):891-7. PubMed ID: 10213226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo analysis of the 'bystander effect': a cytokine cascade.
    Ramesh R; Marrogi AJ; Munshi A; Abboud CN; Freeman SM
    Exp Hematol; 1996 Jun; 24(7):829-38. PubMed ID: 8647234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic efficacy of once-daily oral administration of a Kunitz-type protease inhibitor, bikunin, in a mouse model and in human cancer.
    Kobayashi H; Yagyu T; Inagaki K; Kondo T; Suzuki M; Kanayama N; Terao T
    Cancer; 2004 Feb; 100(4):869-77. PubMed ID: 14770446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour necrosis factor enhances the therapeutic effect of mitoxantrone in human ovarian cancer xenograft.
    Noviello E; Cimoli G; Cosimi A; Allievi E; Galletti P; Parodi S; Russo P
    Cytokine; 1996 Apr; 8(4):330-3. PubMed ID: 9162224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia, chemotherapy, or immunotherapy.
    Haranaka K; Sakurai A; Satomi N
    J Biol Response Mod; 1987 Aug; 6(4):379-91. PubMed ID: 3625230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
    Cao S; McGuire JJ; Rustum YM
    Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.